Pharmather

Published September 30, 2026

Investor Info and Press Releases - PharmaTher (OTCQB: PHRRF) (CSE: PHRM)

Read the full story at Pharmather

5/27/2021. PharmaTher Collaborates with MediSynergics to Develop Patented Ketamine Formulation for Pain Disorders and to Discover Novel Psychedelic.